FR2362631A2 - Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament - Google Patents

Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament

Info

Publication number
FR2362631A2
FR2362631A2 FR7625939A FR7625939A FR2362631A2 FR 2362631 A2 FR2362631 A2 FR 2362631A2 FR 7625939 A FR7625939 A FR 7625939A FR 7625939 A FR7625939 A FR 7625939A FR 2362631 A2 FR2362631 A2 FR 2362631A2
Authority
FR
France
Prior art keywords
pregnene
prepd
oxo
hydroxy
arterial hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7625939A
Other languages
English (en)
Other versions
FR2362631B2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Priority to FR7625939A priority Critical patent/FR2362631A2/fr
Publication of FR2362631A2 publication Critical patent/FR2362631A2/fr
Application granted granted Critical
Publication of FR2362631B2 publication Critical patent/FR2362631B2/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J5/00Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J17/00Normal steroids containing carbon, hydrogen, halogen or oxygen, having an oxygen-containing hetero ring not condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J31/00Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/003Normal steroids containing one or more sulfur atoms not belonging to a hetero ring the S atom directly linked to a ring carbon atom of the cyclopenta(a)hydrophenanthrene skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J7/00Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Les composés répondant à la formule I du brevet principal dont les noms suivent : - le 2,2-diméthyl 3,20-dioxo 7 alpha -acétylthio 21-hydroxy pregn 4-ène; - le 2,2-diméthyl 3,20-dioxo 21-propionyloxy pregn 4-ène. Les composés de l'invention présentent d'intéressantes propriétés pharmacologiques qui justifient leur utilisation comme médicament
FR7625939A 1976-08-27 1976-08-27 Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament Granted FR2362631A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR7625939A FR2362631A2 (fr) 1976-08-27 1976-08-27 Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7625939A FR2362631A2 (fr) 1976-08-27 1976-08-27 Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament

Publications (2)

Publication Number Publication Date
FR2362631A2 true FR2362631A2 (fr) 1978-03-24
FR2362631B2 FR2362631B2 (fr) 1980-03-21

Family

ID=9177186

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7625939A Granted FR2362631A2 (fr) 1976-08-27 1976-08-27 Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament

Country Status (1)

Country Link
FR (1) FR2362631A2 (fr)

Also Published As

Publication number Publication date
FR2362631B2 (fr) 1980-03-21

Similar Documents

Publication Publication Date Title
NO164905C (no) Fremgangsmaate for fremstilling av 16,17-acetal-pregnanderivater.
US4056633A (en) D-homo-20-ketopregnanes and method for inducing anesthesia or narcosis
Oliveto et al. 16-ALKYLATED CORTICOIDS. II. 9α-FLUORO-16α-METHYLPREDNISOLONE 21-ACETATE1
PT86083A (en) Steroidal 17 alpha-silyl ethers and process to corticoids and progesterones
US3781435A (en) Steroid anaesthetics
PH12415A (en) 16a,17-cyclopentylidenedioxy-9a-fluoro-11,21-dihydroxy-1,4-pregnadiene-3,20-dione 21-acetate,anti-inflammatory composition and method of use thereof
FR2362631A2 (fr) Nouveaux 2,2-dimethyl steroides, leur procede de preparation et leur application comme medicament
GB902294A (en) Improvements in or relating to steroids and the manufacture thereof
US3882151A (en) Chemical compounds
Kondo et al. Microbiological Synthesis of 16-Keto Steroids from Steroidal Sapogenins
GB2089808A (en) 5 alpha - and 5 beta -androstane-17 beta - carboxylates and -thiocarboxylates
ES471733A1 (es) Procedimiento para la preparacion de nuevos derivados de la 9-cloroprednisolona
US3763195A (en) Novel 21-acyloxy-3alpha-hydroxy-5alpha-pregnone-11,20-diones
GB1343975A (en) 16beta-difluoromethyl and 16-fifluoromethylene steroids and processes for their preparation
GB1530615A (en) 15,16-methylene-steroids of the pregnane series
US3141877A (en) 9 alpha-hydroxypregnanes and process for production thereof
GB1276419A (en) Novel steroids of the pregnane series and a process for the manufacture thereof
GB1235742A (en) 01beta-METHYL-19-NORPREGNENE COMPOUNDS
ES8507155A3 (es) Metodo para la obtencion de esteroides de la serie de prednisolona
GB1603281A (en) Derivatives of 9-fluoroprednisolone
GB1589585A (en) 12a-halocorticoids
Simonsson Uptake of 3H-cortisol by rabbit polymorphonuclear leukocytes in vitro. III. Structural evidence for a specific glucocorticoid uptake
GB959016A (en) Cyclopentanophenanthrene derivatives
KR790000589B1 (en) Method for producing 6l-fluoro-17,21-dehydroxy-16b-methylpregna-4,9(11)diene-3,20-dione17,21-diacetate
ES8800259A3 (es) Proceso para la preparacion de 6-fluor pregnanos, en especial de 6 alfa-fluor-9beta,11beta-epoxiesteroides.